Guardant Health Inc (NAS:GH)
$ 23.52 -0.08 (-0.34%) Market Cap: 2.89 Bil Enterprise Value: 3.21 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Guardant Health Inc at William Blair Growth Stock Conference Transcript

Jun 07, 2022 / 04:20PM GMT
Release Date Price: $40.35 (+3.41%)
Brian David Weinstein
William Blair & Company L.L.C., Research Division - Partner, Group Head of Life Sciences & Healthcare Analyst

My name is Brian Weinstein. I'm the group head of life sciences here at William Blair. I'm responsible for coverage of Guardant Health, I cover life science tools and diagnostics company. I am required to tell you from my compliance officer, Michael Besenjak that for (technical difficulty)

to go williamblair.com.

Logistically, we have about 30 minutes here. Management will be giving a presentation. I have some questions that I will be asking them at the conclusion of their presentation, and then we will adjourn up to the [Adler] room on the second floor for a breakout session, and we would certainly encourage everybody to join us and ask questions at that time.

With that, I think we can jump in. We're already about 90 seconds in. We're fortunate enough to have both the company's CEO -- the co-CEOs, Helmy Eltoukhy (inaudible); and AmirAli Talasaz is here as well and Mike Bell, the company's CFO; and we'll get to questions, all 3 of them as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot